HofsethBiocare (HBC), the Oslo, Norway-based division of Hofseth International AS, announced they have appointed Missoula, MT-based TSI Health Sciences as exclusive distributor for key markets in the dietary supplement and human nutrition sector. The announcement was made by SjurJenssen, CEO of HofsethBiocare.
According to Jenssen, TSI will complement the HBC team’s commitment to service and science-based support for brand owners marketing this unique range of omega-3 oil ingredients.
“We are pleased to be working with a company that has such a stellar reputation for performance in the marketplace and the integrity and dedication of the TSI executive team and staff,” said Jenssen.
HofsethBiocare holds global patent protection on its method for processing marine biomass in a low temperature, enzyme driven process. This approach yields ingredients like salmon oil that are fresh, pure and 100 percent sustainable, with no impact on wild salmon populations. Rapid processing time and unmatched capacity and traceability make the company’s offerings a truly new and interesting option for soft gel and liquid supplement marketers and manufacturers.
“TSI has been watching the omega-3 space for many years and this is the best ingredient opportunity we haveseen to effectively deliver a point of difference to thiscategory and marketplace,” said Larry Kolb, President, TSI Health Sciences.
“We look forward to building awareness and sales of Hofseth’s proprietary salmon oil ingredients through our globalmarketing offices,” Kolb added.
Jenssen also noted that, “While the industry is focused on the specification, we haveconcentrated on human clinical trials that have shown activity far beyond anything we know to existin the marketplace.In addition, our exceptional supply chain and patented processing method adds to our overall uniqueness.”
For more information visit the HofsethBiocare website at www.HofsethBiocare.com.